Health Products

ETEST Antimicrobial Susceptibility Testing - Polymyxin B (2017-01-23)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
More than 10 numbers, contact manufacturer.
Manufacturer
BioMérieux S.A
376 Chemin De L'orme
Marcy-l'etoile
69280
FRANCE
ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - POLYMYXIN B533400

Introduction

Affected products

ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - POLYMYXIN B

Reason

Following a study conducted on ETEST Polymyxin B with 180 clinical strains (Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae), an underestimation of the Minimum Inhibitory Concentration (MIC) has been observed for Pseudomonas aeruginosa and Acinetobacter species, compared to those obtained using the Broth Micro-Dilution (BMD) reference method. This has led to false susceptible results when the ETEST Polymyxin B results are interpreted using the Clinical and Laboratory Standards Institute (CLSI) breakpoints
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime